BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang HK, Wang JH, Lei WY, Chen CL, Chang CY, Liou LS. Helicobacter pylori infection is associated with an increased risk of Parkinson's disease: A population-based retrospective cohort study. Parkinsonism Relat Disord. 2018;47:26-31. [PMID: 29174171 DOI: 10.1016/j.parkreldis.2017.11.331] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Tucker RM, Augustin AD, Hayee BH, Bjarnason I, Taylor D, Weller C, Charlett A, Dobbs SM, Dobbs RJ. Role of Helicobacters in Neuropsychiatric Disease: A Systematic Review in Idiopathic Parkinsonism. J Clin Med 2020;9:E2159. [PMID: 32650535 DOI: 10.3390/jcm9072159] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Zhang Y, Liu Y, Tang Y, Zhang D, He H, Wu J, Zheng J. Antimicrobial α-defensins as multi-target inhibitors against amyloid formation and microbial infection. Chem Sci 2021;12:9124-39. [PMID: 34276942 DOI: 10.1039/d1sc01133b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kang X, Ploner A, Roelstraete B, Khalili H, Williams DM, Pedersen NL, Ludvigsson JF, Wirdefeldt K. Association Between Microscopic Colitis and Parkinson's Disease in a Swedish Population. Mov Disord 2021;36:1919-26. [PMID: 33764622 DOI: 10.1002/mds.28594] [Reference Citation Analysis]
4 Yu D, Meng X, de Vos WM, Wu H, Fang X, Maiti AK. Implications of Gut Microbiota in Complex Human Diseases. Int J Mol Sci 2021;22:12661. [PMID: 34884466 DOI: 10.3390/ijms222312661] [Reference Citation Analysis]
5 Calvani R, Picca A, Lo Monaco MR, Landi F, Bernabei R, Marzetti E. Of Microbes and Minds: A Narrative Review on the Second Brain Aging. Front Med (Lausanne) 2018;5:53. [PMID: 29552561 DOI: 10.3389/fmed.2018.00053] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
6 Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 2021;9:226. [PMID: 34784980 DOI: 10.1186/s40168-021-01107-9] [Reference Citation Analysis]
7 Kim TJ, Lee H. Benefits of Helicobacter pylori Eradication on Extragastric Diseases. Korean J Helicobacter Up Gastrointest Res 2021;21:275-86. [DOI: 10.7704/kjhugr.2021.0041] [Reference Citation Analysis]
8 Reshetnyak VI, Burmistrov AI, Maev IV. Helicobacter pylori: Commensal, symbiont or pathogen? . World J Gastroenterol 2021; 27(7): 545-560 [PMID: 33642828 DOI: 10.3748/wjg.v27.i7.545] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 20.0] [Reference Citation Analysis]
9 Pfeiffer RF, Isaacson SH, Pahwa R. Clinical implications of gastric complications on levodopa treatment in Parkinson's disease. Parkinsonism Relat Disord 2020;76:63-71. [PMID: 32461054 DOI: 10.1016/j.parkreldis.2020.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
10 Peng C, Hu Y, Ge ZM, Zou QM, Lyu NH. Diagnosis and treatment of Helicobacter pylori infections in children and elderly populations. Chronic Dis Transl Med 2019;5:243-51. [PMID: 32055783 DOI: 10.1016/j.cdtm.2019.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 Murros KE. Hydrogen Sulfide Produced by Gut Bacteria May Induce Parkinson’s Disease. Cells 2022;11:978. [DOI: 10.3390/cells11060978] [Reference Citation Analysis]
12 Bhattarai Y, Kashyap PC. Parkinson's disease: Are gut microbes involved? Am J Physiol Gastrointest Liver Physiol 2020;319:G529-40. [PMID: 32877215 DOI: 10.1152/ajpgi.00058.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wu M, Huang J, Chen H, Wei JC. Effect of early eradication therapy on systemic lupus erythematosus risk in patients with Helicobacter pylori infection: a nationwide population-based cohort study. Lupus 2020;29:751-60. [DOI: 10.1177/0961203320923393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhao Z, Li F, Ning J, Peng R, Shang J, Liu H, Shang M, Bao XQ, Zhang D. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota-gut-brain axis. Acta Pharm Sin B 2021;11:2859-79. [PMID: 34589401 DOI: 10.1016/j.apsb.2021.03.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Tan AH, Lim S, Mahadeva S, Loke MF, Tan JY, Ang BH, Chin KP, Mohammad Adnan AF, Ong SMC, Ibrahim AI, Zulkifli N, Lee JK, Lim WT, Teo YT, Kok YL, Ng TY, Tan AGS, Zulkifle IM, Ng CK, Ee SS, Arafin S, Mohamad Shukori K, Vadivelu JS, Marras C, Fox SH, Lang AE. Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo‐Controlled Trial. Mov Disord 2020;35:2250-60. [DOI: 10.1002/mds.28248] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
16 Limphaibool N, Iwanowski P, Holstad MJV, Kobylarek D, Kozubski W. Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications. Front Neurol 2019;10:652. [PMID: 31275235 DOI: 10.3389/fneur.2019.00652] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
17 Kramer P. Mitochondria-Microbiota Interaction in Neurodegeneration. Front Aging Neurosci 2021;13:776936. [PMID: 35002678 DOI: 10.3389/fnagi.2021.776936] [Reference Citation Analysis]
18 Uyar GÖ, Yildiran H. A nutritional approach to microbiota in Parkinson's disease. Biosci Microbiota Food Health 2019;38:115-27. [PMID: 31763115 DOI: 10.12938/bmfh.19-002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
19 Franceschi F, Covino M, Roubaud Baudron C. Review: Helicobacter pylori and extragastric diseases. Helicobacter. 2019;24 Suppl 1:e12636. [PMID: 31486239 DOI: 10.1111/hel.12636] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
20 Chen H, Wang K, Scheperjans F, Killinger B. Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses. Neurobiol Dis 2021;163:105601. [PMID: 34954321 DOI: 10.1016/j.nbd.2021.105601] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Tayara K, Espinosa-Oliva AM, García-Domínguez I, Ismaiel AA, Boza-Serrano A, Deierborg T, Machado A, Herrera AJ, Venero JL, de Pablos RM. Divergent Effects of Metformin on an Inflammatory Model of Parkinson's Disease. Front Cell Neurosci 2018;12:440. [PMID: 30519161 DOI: 10.3389/fncel.2018.00440] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
22 Sampson T. The impact of indigenous microbes on Parkinson's disease. Neurobiology of Disease 2020;135:104426. [DOI: 10.1016/j.nbd.2019.03.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
23 Fu P, Gao M, Yung KKL. Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis. ACS Chem Neurosci 2020;11:395-405. [PMID: 31876406 DOI: 10.1021/acschemneuro.9b00607] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 17.5] [Reference Citation Analysis]
24 Wang C, Zheng C. Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenerative Diseases Targeting Microbe-Host Interactions. Front Pharmacol 2022;13:875349. [DOI: 10.3389/fphar.2022.875349] [Reference Citation Analysis]
25 Hasan S, Mielke MM, Ahlskog JE, Bower J, Turcano P, Savica R. Infections or Sepsis Preceding Clinically Diagnosed α-Synucleinopathies: A Case-Control Study. Mov Disord 2020;35:1684-9. [PMID: 32479692 DOI: 10.1002/mds.28111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Yanyan S, Yanlei G, Ting Z, Shigang D. Hydrotalcite Can Prevent the Damaging Effects of Helicobacter Pylori on Gastric Epithelial Cells. Microsc Microanal 2018;24:277-83. [PMID: 29952282 DOI: 10.1017/S1431927618000314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Cannon T, Gruenheid S. Microbes and Parkinson’s disease: from associations to mechanisms. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.01.004] [Reference Citation Analysis]
28 Chen H, Ritz B. The Search for Environmental Causes of Parkinson's Disease: Moving Forward. J Parkinsons Dis 2018;8:S9-S17. [PMID: 30584168 DOI: 10.3233/JPD-181493] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 9.3] [Reference Citation Analysis]
29 Wang H, Liu X, Tan C, Zhou W, Jiang J, Peng W, Zhou X, Mo L, Chen L. Bacterial, viral, and fungal infection-related risk of Parkinson's disease: Meta-analysis of cohort and case-control studies. Brain Behav. 2020;10:e01549. [PMID: 32017453 DOI: 10.1002/brb3.1549] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
30 Lotz SK, Blackhurst BM, Reagin KL, Funk KE. Microbial Infections Are a Risk Factor for Neurodegenerative Diseases. Front Cell Neurosci 2021;15:691136. [PMID: 34305533 DOI: 10.3389/fncel.2021.691136] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Tan AH, Lim SY, Lang AE. The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic. Nat Rev Neurol 2022. [PMID: 35750883 DOI: 10.1038/s41582-022-00681-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol 2018; 24(29): 3204-3221 [PMID: 30090002 DOI: 10.3748/wjg.v24.i29.3204] [Cited by in CrossRef: 115] [Cited by in F6Publishing: 82] [Article Influence: 28.8] [Reference Citation Analysis]
33 Zendehdel A, Roham M. Biological evidence of the relationship between Helicobacter pylori and associated extragastric diseases. J Cell Biochem 2019;120:12128-40. [DOI: 10.1002/jcb.28681] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
34 Bai F, Li X. Association of Helicobacter pylori treatment with Parkinsonism and related disorders: A systematic review and meta-analysis. Life Sci 2021;281:119767. [PMID: 34216625 DOI: 10.1016/j.lfs.2021.119767] [Reference Citation Analysis]
35 Reshetnyak VI, Burmistrov AI, Maev IV. Helicobacter pylori: Commensal, symbiont or pathogen? World J Gastroenterol 2021;27:545-60. [PMID: 33642828 DOI: 10.3748/wjg.v27.i7.545] [Reference Citation Analysis]
36 McGee DJ, Lu XH, Disbrow EA. Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson's Disease. J Parkinsons Dis 2018;8:367-74. [PMID: 29966206 DOI: 10.3233/JPD-181327] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 9.7] [Reference Citation Analysis]
37 Chandra S, Alam MT, Dey J, Sasidharan BCP, Ray U, Srivastava AK, Gandhi S, Tripathi PP. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders. Curr Top Med Chem 2020;20:1142-53. [PMID: 32282304 DOI: 10.2174/1568026620666200413091101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
38 Ceppa FA, Izzo L, Sardelli L, Raimondi I, Tunesi M, Albani D, Giordano C. Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling. Front Cell Infect Microbiol 2020;10:297. [PMID: 32733812 DOI: 10.3389/fcimb.2020.00297] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
39 Meng L, Shen L, Ji HF. Impact of infection on risk of Parkinson's disease: a quantitative assessment of case-control and cohort studies. J Neurovirol 2019;25:221-8. [PMID: 30632012 DOI: 10.1007/s13365-018-0707-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
40 Tan W, Zhang Q, Dong Z, Yan Y, Fu Y, Liu X, Zhao B, Duan X. Phosphatidylcholine Ameliorates LPS-Induced Systemic Inflammation and Cognitive Impairments via Mediating the Gut–Brain Axis Balance. J Agric Food Chem 2020;68:14884-95. [DOI: 10.1021/acs.jafc.0c06383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Zuo Y, Jing Z, Bie M, Xu C, Hao X, Wang B. Association between Helicobacter pylori infection and the risk of colorectal cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e21832. [PMID: 32925719 DOI: 10.1097/MD.0000000000021832] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Sheng S, Zhao S, Zhang F. Insights into the roles of bacterial infection and antibiotics in Parkinson’s disease. Front Cell Infect Microbiol 2022;12:939085. [DOI: 10.3389/fcimb.2022.939085] [Reference Citation Analysis]
43 Shen T, Yue Y, He T, Huang C, Qu B, Lv W, Lai HY. The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis. Front Aging Neurosci 2021;13:636545. [PMID: 33643026 DOI: 10.3389/fnagi.2021.636545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
44 Smeyne RJ, Noyce AJ, Byrne M, Savica R, Marras C. Infection and Risk of Parkinson's Disease. J Parkinsons Dis 2021;11:31-43. [PMID: 33361610 DOI: 10.3233/JPD-202279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
45 Menozzi E, Macnaughtan J, Schapira AHV. The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance. Ann Med 2021;53:611-25. [PMID: 33860738 DOI: 10.1080/07853890.2021.1890330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
46 Skjærbæk C, Knudsen K, Horsager J, Borghammer P. Gastrointestinal Dysfunction in Parkinson's Disease. J Clin Med 2021;10:493. [PMID: 33572547 DOI: 10.3390/jcm10030493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
47 Baj J, Forma A, Flieger W, Morawska I, Michalski A, Buszewicz G, Sitarz E, Portincasa P, Garruti G, Flieger M, Teresiński G. Helicobacter pylori Infection and Extragastric Diseases-A Focus on the Central Nervous System. Cells 2021;10:2191. [PMID: 34571840 DOI: 10.3390/cells10092191] [Reference Citation Analysis]
48 Kang X, Ploner A, Ludvigsson JF, Williams DM, Larsson H, Pedersen NL, Wirdefeldt K. Clostridium difficile infection and risk of Parkinson's disease: a Swedish population-based cohort study. Eur J Neurol 2020;27:2134-41. [PMID: 32538502 DOI: 10.1111/ene.14400] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Elfil M, Kamel S, Kandil M, Koo BB, Schaefer SM. Implications of the Gut Microbiome in Parkinson's Disease. Mov Disord 2020;35:921-33. [DOI: 10.1002/mds.28004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]